1. Home
  2. NTRA vs JBHT Comparison

NTRA vs JBHT Comparison

Compare NTRA & JBHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • JBHT
  • Stock Information
  • Founded
  • NTRA 2003
  • JBHT 1961
  • Country
  • NTRA United States
  • JBHT United States
  • Employees
  • NTRA N/A
  • JBHT N/A
  • Industry
  • NTRA Medical Specialities
  • JBHT Trucking Freight/Courier Services
  • Sector
  • NTRA Health Care
  • JBHT Industrials
  • Exchange
  • NTRA Nasdaq
  • JBHT Nasdaq
  • Market Cap
  • NTRA 13.7B
  • JBHT 16.3B
  • IPO Year
  • NTRA 2015
  • JBHT N/A
  • Fundamental
  • Price
  • NTRA $129.95
  • JBHT $167.48
  • Analyst Decision
  • NTRA Strong Buy
  • JBHT Buy
  • Analyst Count
  • NTRA 15
  • JBHT 16
  • Target Price
  • NTRA $123.64
  • JBHT $181.25
  • AVG Volume (30 Days)
  • NTRA 1.2M
  • JBHT 726.4K
  • Earning Date
  • NTRA 11-06-2024
  • JBHT 10-15-2024
  • Dividend Yield
  • NTRA N/A
  • JBHT 1.02%
  • EPS Growth
  • NTRA N/A
  • JBHT N/A
  • EPS
  • NTRA N/A
  • JBHT 5.81
  • Revenue
  • NTRA $1,360,503,000.00
  • JBHT $12,340,138,000.00
  • Revenue This Year
  • NTRA $42.99
  • JBHT N/A
  • Revenue Next Year
  • NTRA $13.11
  • JBHT $6.98
  • P/E Ratio
  • NTRA N/A
  • JBHT $29.02
  • Revenue Growth
  • NTRA 46.13
  • JBHT N/A
  • 52 Week Low
  • NTRA $36.90
  • JBHT $153.12
  • 52 Week High
  • NTRA $128.28
  • JBHT $219.51
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 66.43
  • JBHT 51.51
  • Support Level
  • NTRA $114.62
  • JBHT $165.25
  • Resistance Level
  • NTRA $118.52
  • JBHT $171.42
  • Average True Range (ATR)
  • NTRA 4.62
  • JBHT 4.11
  • MACD
  • NTRA 0.87
  • JBHT -0.60
  • Stochastic Oscillator
  • NTRA 99.77
  • JBHT 45.12

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About JBHT J.B. Hunt Transport Services Inc.

J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (48% of sales in 2023), dedicated trucking services that provide customer-specific fleet needs (28%), for-hire truckload (6%), heavy goods final-mile delivery (7%), and asset-light truck brokerage (11%).

Share on Social Networks: